Rachel A Ridgway

13PUBLICATIONS
158CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 18, 2025
Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation.

Georgios Kanellos, Chiara Giacomelli, Alexander Raven

|Nov 25, 2025
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.

Mark White, Megan L Mills, Laura M Millett

|Jun 03, 2024
Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.

Sudhir B Malla, Ryan M Byrne, Maxime W Lafarge

|Feb 15, 2024
Characterizing Neutrophil Subtypes in Cancer Using scRNA Sequencing Demonstrates the Importance of IL1β/CXCR2 Axis in Generation of Metastasis-specific Neutrophils.

Rana Fetit, Alistair S McLaren, Mark White

|Feb 14, 2024
Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.

Sudhir B Malla, Ryan M Byrne, Maxime W Lafarge

|Aug 25, 2023
Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression.

Peter Bailey, Rachel A Ridgway, Patrizia Cammareri

Pageof 3

Frequent Collaborators

13 joint publications

Owen J Sansom

10 joint publications

Andrew D Campbell

8 joint publications

Colin Nixon

7 joint publications

Philip D Dunne